A single-center, open-label, single-arm, phase I study with dose expansion cohort of sacituzumab govitecan in combination with cisplatin for patients with platinum sensitive recurrent ovarian and ...
A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a median age of 65 years (IQR 59-71), 50% with positive surgical margins, 51% ...
In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...
4hon MSN
Low-dose radiation therapy offers substantial relief to people with painful knee osteoarthritis
A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback